Pioglitazone HCL and Metformin HCL 15 mg/1

Pioglitazone HCL and Metformin HCL 15 mg/1 tablets combine two active ingredients for managing blood sugar levels. This oral medication is commonly used in diabetes care to improve insulin sensitivity and glucose control.

Pioglitazone HCL and Metformin HCL tablets are typically used to manage type 2 diabetes. Pioglitazone works by improving insulin sensitivity in the body, while Metformin helps reduce glucose production in the liver. Together, they assist in maintaining healthy blood sugar levels. This combination is often prescribed when diet and exercise alone are not sufficient to control blood sugar.

Common effects of Pioglitazone HCL and Metformin HCL tablets may include weight gain, headaches, and gastrointestinal discomfort. Some users might experience dizziness or mild flu-like symptoms. These effects vary and are not experienced by everyone.

It is important to follow the advice of a healthcare provider when taking Pioglitazone HCL and Metformin HCL tablets. Regular monitoring of blood sugar levels is recommended. Patients with certain medical conditions, such as liver or heart disease, should discuss their health status with a healthcare provider before use.

Pioglitazone HCL and Metformin HCL tablets may interact with other medications, including certain antibiotics and antifungal drugs. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of side effects. Always inform healthcare providers about all medications being taken.